LCN2 and metabolic dysfunction-associated steatohepatitis: The upregulation of LCN2 expression in damaged hepatocytes and infiltrating immune cells has been observed in various liver diseases, including hepatitis, alcoholic liver disease, and non-alcoholic steatohepatitis [44, 45].